- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 10:38 | iZafe Group: Monthly Update July - Summer Calm, Stress Test and Continued Momentum | 167 | ACCESS Newswire | STOCKHOLM, SE / ACCESS Newswire / August 8, 2025 / iZafe Group (STO:IZAFE-B) - July is traditionally a quieter month, something we accounted for in our planning and budget. But that doesn't mean we've... ► Artikel lesen | |
| 09.07. | iZafe Group Signs Agreement with AddSecure Smart Care Oy to launch Dosell in Finland | 259 | ACCESS Newswire | STOCKHOLM, SE / ACCESS Newswire / July 9, 2025 / iZafe Group (STO:IZAFE-B) - iZafe Group AB (publ.) has signed an agreement with AddSecure Smart Care Oy for the distribution of the medication dispenser... ► Artikel lesen | |
| 07.07. | iZafe Group: Monthly Update June - New Share Issue, Shareholder Campaign, and Continued International Growth | 230 | ACCESS Newswire | STOCKHOLM, SE / ACCESS Newswire / July 7, 2025 / iZafe Group (STO:IZAFE-B) - Strong Start to the Summer - and Continued Focus on Reaching 10 MSEK in ARRJune was marked by strategic initiatives and a... ► Artikel lesen | |
| IZAFE GROUP Aktie jetzt für 0€ handeln | |||||
| 27.06. | iZafe Group Resolves on a Directed Share Issue of Approximately SEK 10 million | 269 | ACCESS Newswire | STOCKHOLM, SE / ACCESS Newswire / June 27, 2025 / iZafe Group (STO:IZAFE-B.ST) ("iZafe" or the "Company") announces today that the Board of Directors has resolved, based on the authorization granted... ► Artikel lesen | |
| 05.06. | iZafe Group: Monthly Update May - Surpassing 1,000 Units and Growing Strategic Partnerships | 276 | ACCESS Newswire | STOCKHOLM, SE / ACCESS Newswire / June 5, 2025 / iZafe Group (STO:IZAFE-B) - May has been an eventful month where we took yet another important step forward. The number of active billable Dosell units... ► Artikel lesen | |
| 03.06. | iZafe Group: Dosell Reaches 1,000 Units in Operation - Celebrates Milestone with Investor Event in Stockholm | 258 | ACCESS Newswire | STOCKHOLM, SWEDEN / ACCESS Newswire / June 3, 2025 / iZafe Group (STO:IZAFE-B) ("iZafe" or "the Company") today announces that its subsidiary Dosell has reached a significant milestone: more than 1... ► Artikel lesen | |
| 20.05. | iZafe Group: iZafe signs Letter of Intent with JDM Innovation with the Goal to Initiate a Strategic Partnership in Europe | 318 | ACCESS Newswire | STOCKHOLM, SE / ACCESS Newswire / May 20, 2025 / iZafe Group (STO:IZAFE-B) - iZafe Group AB (publ) ("iZafe" or "the Company") today announces that it has signed a Letter of Intent (LOI) with German... ► Artikel lesen | |
| 08.05. | iZafe Group: April Monthly Report - Continued Growth as We Approach 1,000 Active Units | 216 | ACCESS Newswire | STOCKHOLM, SE / ACCESS Newswire / May 8, 2025 / iZafe Group (STO:IZAFE-B) - April was a month marked by concrete expansion, deepened customer relationships, and sustained strong interest from new stakeholders.... ► Artikel lesen | |
| 25.04. | iZafe Group Q1 Interim Report, January-March 2025 | 264 | ACCESS Newswire | STOCKHOLM, SE / ACCESS Newswire / April 25, 2025 / iZafe Group (STO:IZAFE-B) - iZafe Group AB (publ.) presents today, April 25th, its report for the first quarter.Financial Performance in SummaryTotal... ► Artikel lesen | |
| 03.04. | iZafe Group: March Monthly Update - Continued Growth and Important Progress | 242 | ACCESS Newswire | STOCKHOLM, SE / ACCESS Newswire / April 3, 2025 / iZafe Group (STO:IZAFE-B) - After an increase of billable Dosell units by 25% in January and an additional 9% in February, the number rose by another... ► Artikel lesen | |
| 21.03. | iZafe Group AB Changes Certified Adviser to Carnegie Investment Bank AB | 274 | ACCESS Newswire | STOCKHOLM, SWEDEN / ACCESS Newswire / March 21, 2025 / iZafe Group (STO:IZAFE-B) (publ) announces today that the company is changing its Certified Adviser from Mangold Fondkommission AB to Carnegie... ► Artikel lesen | |
| 06.03. | Increased Demand and Successful Launch - iZafe Group Strengthens Its Position | 2.114 | ACCESS Newswire | STOCKHOLM, SE / ACCESS Newswire / March 6, 2025 / iZafe Group (STO:IZAFE-B) February was an intense and forward-looking month for iZafe Group. We continue to accelerate our growth and strengthen our... ► Artikel lesen | |
| 27.02. | iZafe Group's Board Member Magnus Engman Purchases 200,000 Shares | 312 | ACCESS Newswire | STOCKHOLM, SE / ACCESSWIRE / February 27, 2025 / iZafe Group (STO:IZAFE-B) iZafe Group's board member, Magnus Engman, acquired 200,000 B-shares in the company on February 26, at a total value of 52... ► Artikel lesen | |
| 24.02. | iZafe Group: Launch of Dosell Sales in Spain - A Groundbreaking Solution to Improve Medication Adherence | 338 | ACCESS Newswire | STOCKHOLM, SWEDEN / ACCESS Newswire / February 24, 2025 / iZafe Group (STO:IZAFE-B.ST) iZafe Group AB ("iZafe Group") proudly announces the sales launch of Dosell in Spain through a strategic partnership... ► Artikel lesen | |
| 14.02. | iZafe Group Q4 Interim Report, October-December 2024 and New Forecast | 264 | ACCESS Newswire | STOCKHOLM, SWEDEN / ACCESS Newswire / February 14, 2025 / iZafe Group (STO:IZAFE-B.ST) iZafe Group AB (publ.) presents today, February 14, its report for the fourth quarter.Financial Performance in... ► Artikel lesen | |
| 06.02. | Strong Start to 2025 - iZafe Group Accelerates Dosell's Growth | 215 | ACCESS Newswire | STOCKHOLM, SE / ACCESS Newswire / February 6, 2025 / iZafe Group (STO:IZAFE-B) 2025 has started on a positive note for iZafe Group, with steady growth in Dosell and increasing demand across multiple... ► Artikel lesen | |
| 20.12.24 | The Year in Review: Reflections from iZafe Group's CEO on 2024 | 320 | ACCESS Newswire | STOCKHOLM, SE / ACCESSWIRE / December 20, 2024 / iZafe Group (STO:IZAFE-B) 2024 has been a transformative year for iZafe Group, where we have laid a strong foundation for the future. We have multiplied... ► Artikel lesen | |
| 06.12.24 | iZafe Group AB Strengthens Global Position with UMO Certification for Dosell | 376 | ACCESS Newswire | STOCKHOLM, SWEDEN / ACCESSWIRE / December 6, 2024 / iZafe Group (STO:IZAFE-B) announces that its product, Dosell, is now certified for integration with Enovation UMO, the monitoring solution for medical... ► Artikel lesen | |
| 18.11.24 | iZafe Group: Dosell Secures Large Order for 1,000 Units in the Netherlands - Order Value of SEK 3 Million and Up to SEK 400,000/Month in Recurring Revenue | 368 | ACCESS Newswire | STOCKHOLM, SE / ACCESSWIRE / November 18, 2024 / iZafe Group (STO:IZAFE-B) iZafe Group AB (publ) ("iZafe") announces today that it has received a new confirmed order for an additional 1,000 Dosell units... ► Artikel lesen | |
| 14.11.24 | iZafe Group's CFO, Marius Sandberg, Purchases 177,793 Shares | 257 | ACCESS Newswire | STOCKHOLM, SWEDEN / ACCESSWIRE / November 14, 2024 / iZafe Group (STO:IZAFE-B) iZafe Group's CFO, Marius Sandberg, has today acquired 177,793 B-shares in the company at a value of SEK 34,909 (SEK 0.196... ► Artikel lesen |
1 2 Weiter >>
26 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| FRESENIUS | 43,900 | +3,83 % | Fresenius Kabi lizensiert Vedolizumab-Biosimilar-Kandidaten ein | DJ Fresenius Kabi lizensiert Vedolizumab-Biosimilar-Kandidaten ein
DOW JONES--Der Gesundheitskonzern Fresenius hat einen weiteren Schritt zur Vergrößerung seiner Biosimilars-Pipeline unternommen.... ► Artikel lesen | |
| SIEMENS HEALTHINEERS | 46,310 | +0,30 % | EQS-DD: Siemens Healthineers AG: Dr. Bernhard Montag, Kauf | Meldung und öffentliche Bekanntgabe der Geschäfte von Personen, die Führungsaufgaben wahrnehmen, sowie in enger Beziehung zu ihnen stehenden Personen
01.08.2025 / 16:44... ► Artikel lesen | |
| ECKERT & ZIEGLER | 59,15 | -9,00 % | Eckert&Ziegler-Aktie verliert 2,70 Prozent (64,90 €) | Am deutschen Aktienmarkt notiert die Aktie von Eckert&Ziegler gegenwärtig leichter. Das Papier kostete zuletzt 64,90 Euro. Die Aktie von Eckert&Ziegler verzeichnet derzeit einen Kursverlust von 2,70... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 41,120 | +0,49 % | Fresenius Medical Care Q2 2025: Fresenius Medical Care-Aktie: Gewinn steigt deutlich - Aktie unterbewertet | © Foto: picture alliance/dpa/CTK | Slavomir KubesFresenius Medical Care befindet sich auf dem Weg der Besserung.Fresenius Medical Care (FMC) gehört weltweit zu den führenden Anbietern von Dialysebehandlungen... ► Artikel lesen | |
| CARL ZEISS MEDITEC | 43,200 | -0,28 % | Carl Zeiss Meditec: Die Analysten sind optimistisch, die Trader nicht | Als Reaktion auf die am Donnerstag vorgelegten Neun-Monats-Zahlen sackte die Carl Zeiss Meditec-Aktie zeitweise über 14 Prozent durch, bevor sie mit immer noch drastischen -9,52 Prozent aus dem Handel... ► Artikel lesen | |
| GERRESHEIMER | 46,000 | +1,28 % | Energiekontor, Gerresheimer, K+S, Lufthansa, PVA TePla, Siltronic - Aktien-Positionen der Short-Seller | Wer Aktien leerverkauft, also auf fallende Kurse spekuliert (Shortselling), unterliegt bestimmten Transparenzpflichten. Aktuelle Meldungen über Leerverkäufe geben Aufschluss darüber. Diese Vorgaben... ► Artikel lesen | |
| UNITEDHEALTH | 211,80 | +0,88 % | Erholung nach Jobdaten-Rücksetzer - Palantir, Tesla, Disney, UnitedHealth, Microsoft, Meta | Die neuen, als willkürlich empfundenen US-Zölle haben zum Wochenschluss auch an der Wall Street für deutliche Verluste gesorgt. Vor dem Hintergrund der Zollpolitik und schwacher Arbeitsmarktdaten beendeten... ► Artikel lesen | |
| PROGYNY | 22,600 | -1,99 % | Progyny, Inc. Announces Second Quarter 2025 Results | Reports Record Revenue of $332.9 Million, Reflecting 9.5% GrowthGenerates $55.5 Million in Quarterly Operating Cash Flow and Record $105.3 Million over the First Half of 2025 Raises Full Year Guidance... ► Artikel lesen | |
| OPTIMIZERX | 14,690 | +13,88 % | OptimizeRx Corporation: OptimizeRx Reports Second Quarter 2025 Financial Results and Updates Fiscal Year 2025 Guidance | Q2 revenue of $29.2 million, increased 55% year-over-yearQ2 gross profit increased 59% year-over-year to $18.6 millionPaid down $4.5 million of principal on outstanding term loan during Q2Increased... ► Artikel lesen | |
| THERMO FISHER | 388,65 | -0,42 % | $1000 Invested In Thermo Fisher Scientific 10 Years Ago Would Be Worth This Much Today | ||
| HIMS & HERS HEALTH | 43,640 | -0,39 % | Nachbörslicher Absturz: Telemedizin-Rakete Hims & Hers: Milliarden-Ziel bis 2030 - aber die Aktie crasht | © Foto: Thomas Fuller - SOPA Images via ZUMA Press WireRekordzahlen, neue Märkte, große Visionen: Hims & Hers wächst rasant. Die Börse reagiert allerdings knallhart. Anleger drücken die Aktie nachbörslich... ► Artikel lesen | |
| DRAEGERWERK | 67,00 | -0,15 % | Draegerwerk AG & Co. KGaA: Dräger bestätigt Q2-Trends und starker Auftragseingang unterstützt Visibilität. HALTEN. | Dräger bestätigt die Ergebnisse für das 2. Quartal 2025 mit einem Umsatzanstieg von 1,8% (wb.) auf 780 Mio EUR und einem EBIT von 20 Mio EUR, was den Wegfall von Einmalerträgen aus dem Vorjahr widerspiegelt.... ► Artikel lesen | |
| GENEDX | 105,48 | -0,44 % | Rackspace US, Inc.: Rackspace Technology und Sema4.ai stellen die erste skalierbare KI-Agent-Lösung für Unternehmen vor | Die unternehmensgerechte Lösung schließt die Lücke zwischen KI-Experimenten und umfassender TransformationSAN ANTONIO, June 18, 2025®) und die Anwendungsmanagement-Expertise von Rackspace mit der fortschrittlichen... ► Artikel lesen | |
| INTUITIVE SURGICAL | 404,70 | +0,41 % | Schock-News für Intuitive Surgical Anleger vor dem Wochenende: So müssen Sie heute noch auf diese Sondermeldung reagieren! | ||
| CLARIANE | 4,352 | -0,46 % | Clariane: Tap issue in the amount of €100M of its notes due June 27th, 2030, bringing its total amount to €500m | Press release August 1st, 2025 Clariane has successfully completed a tap issue in the amount of 100 million euros of its notes due June 27, 2030, bringing its total amount to 500 million euros Paris... ► Artikel lesen |
IZAFE GROUP AB gehört der Branche Gesundheitswesen an. Die relative Kursveränderung beträgt aktuell 0,00 % bei einem Aktienkurs von 0,023 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu IZAFE GROUP AB finden Sie auf Wallstreet Online.